Diabetes Clinical Trials in Chicago

Showing 321-340 of 574 trials

Extended Follow-Up After Islet Transplantation in T1D

NCT01369082

The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications and islet function.

Type 1 Diabetes (T1D)Islet Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)75 participantsStarted May 2011

San Francisco, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDPhase 22.2 miles

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

NCT00495469

This is a dose-ranging study to evaluate the efficacy, safety and tolerability of a range of doses of GSK189075 (an SGLT2 inhibitor) compared to placebo, administered over 12 weeks in treatment-naive subjects with type 2 diabetes mellitus

Diabetes Mellitus, Type 2

GlaxoSmithKline250 participantsStarted Aug 2007

Mesa, Arizona, United States • Artesia, California, United States • Buena Park, California, United States +154 more locations

Extended Follow-Up After Islet Transplantation in T1D

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Diabetes Trials in Other Cities

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

NEAT! Technology to Increase Breaks in Sedentary Behavior in Adults With Diabetes

Effect of Nutritional Products in Subjects With Type 2 Diabetes

Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 Diabetes

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

Thiazolidinedione Intervention With Vitamin D Evaluation

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Other Conditions in Chicago